W. TOSCH

910 total citations
17 papers, 669 citations indexed

About

W. TOSCH is a scholar working on Pharmacology, Organic Chemistry and Molecular Medicine. According to data from OpenAlex, W. TOSCH has authored 17 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 6 papers in Organic Chemistry and 6 papers in Molecular Medicine. Recurrent topics in W. TOSCH's work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Antibiotic Resistance in Bacteria (6 papers) and Synthesis of β-Lactam Compounds (4 papers). W. TOSCH is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (8 papers), Antibiotic Resistance in Bacteria (6 papers) and Synthesis of β-Lactam Compounds (4 papers). W. TOSCH collaborates with scholars based in Switzerland and United States. W. TOSCH's co-authors include O. Zák, Alexander Tomasz, Robert Cozens, Elaine Tuomanen, Peter Traxler, W. G. Kump, Merle A. Sande, Wolfgang Zimmermann, W. A. Vischer and Peter Schneider and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

W. TOSCH

17 papers receiving 637 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W. TOSCH Switzerland	10	274	237	165	158	117	17	669
K. Coleman United States	8	414 1.5×	305 1.3×	145 0.9×	138 0.9×	187 1.6×	8	839
Megumi Kono Japan	14	349 1.3×	174 0.7×	85 0.5×	142 0.9×	229 2.0×	48	606
Patrick J. Cassidy United States	6	312 1.1×	325 1.4×	229 1.4×	108 0.7×	111 0.9×	8	786
H. M. Van Den Elzen Canada	10	356 1.3×	499 2.1×	266 1.6×	183 1.2×	137 1.2×	10	832
Barbara A. Pelak United States	14	329 1.2×	241 1.0×	302 1.8×	101 0.6×	205 1.8×	28	939
B Slocombe United Kingdom	13	322 1.2×	264 1.1×	252 1.5×	75 0.5×	314 2.7×	31	870
Nigel A. C. Curtis United Kingdom	16	392 1.4×	527 2.2×	336 2.0×	200 1.3×	313 2.7×	25	946
Paul Actor United States	17	277 1.0×	177 0.7×	320 1.9×	85 0.5×	231 2.0×	72	988
Ingegerd Gustafsson Sweden	11	343 1.3×	315 1.3×	183 1.1×	134 0.8×	85 0.7×	18	824
David Orr Germany	14	257 0.9×	248 1.0×	168 1.0×	68 0.4×	275 2.4×	21	727

Countries citing papers authored by W. TOSCH

Since Specialization

Citations

This map shows the geographic impact of W. TOSCH's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. TOSCH with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. TOSCH more than expected).

Fields of papers citing papers by W. TOSCH

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. TOSCH. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. TOSCH. The network helps show where W. TOSCH may publish in the future.

Co-authorship network of co-authors of W. TOSCH

This figure shows the co-authorship network connecting the top 25 collaborators of W. TOSCH. A scholar is included among the top collaborators of W. TOSCH based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. TOSCH. W. TOSCH is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Traxler, Peter, W. G. Kump, Κ. T. Mueller, & W. TOSCH. (1990). Hypolipidemic activity of rifamycin derivatives. Journal of Medicinal Chemistry. 33(2). 552–560. 12 indexed citations

Zák, O., Marc Lang, Robert Cozens, et al.. (1988). Penems: In Vitro and In Vivo Experiments. The Journal of Clinical Pharmacology. 28(2). 128–135. 5 indexed citations

Capraro, Hans‐Georg, et al.. (1988). Synthesis and biological activity of 2-lactonyl penems.. The Journal of Antibiotics. 41(6). 759–770. 11 indexed citations

Traxler, Peter, W. TOSCH, & O. Zák. (1987). Papulacandins - Synthesis and biological activity of papulacandin B derivatives.. The Journal of Antibiotics. 40(8). 1146–1164. 24 indexed citations

Wehrli, W., Wolfgang Zimmermann, W. G. Kump, et al.. (1987). CGP 4832, a new semisynthetic rifamycin derivative highly active against some gram-negative bacteria.. The Journal of Antibiotics. 40(12). 1733–1739. 21 indexed citations

Lang, Marc, et al.. (1987). Penems : Synthesis and antibacterial activity of 2-(1-azolyl) derivatives.. The Journal of Antibiotics. 40(2). 217–220. 3 indexed citations

TOSCH, W., et al.. (1987). [Quantitative sensitivity determination of bacteria. Indications and methods].. PubMed. 117(14). 509–17. 1 indexed citations

LANG, M., et al.. (1986). The penems, a new class of .BETA.-lactam antibiotics. 7. Synthesis and antimicrobial activity of 2-heterocyclylmercaptoalkyl derivatives.. The Journal of Antibiotics. 39(4). 525–534. 5 indexed citations

Lang, Marc, et al.. (1986). (+)‐(5R,6S)‐2‐(1′‐Aminoalkyl)‐6‐(hydroxyalkyl)penem‐3‐carboxylic Acids. Helvetica Chimica Acta. 69(7). 1576–1580. 6 indexed citations

10.

Cozens, Robert, et al.. (1986). Evaluation of the bactericidal activity of beta-lactam antibiotics on slowly growing bacteria cultured in the chemostat. Antimicrobial Agents and Chemotherapy. 29(5). 797–802. 129 indexed citations

11.

Tuomanen, Elaine, Robert Cozens, W. TOSCH, O. Zák, & Alexander Tomasz. (1986). The Rate of Killing of Escherichia coli by -Lactam Antibiotics Is Strictly Proportional to the Rate of Bacterial Growth. Microbiology. 132(5). 1297–1304. 366 indexed citations

12.

TOSCH, W. & R. Schnell. (1985). Possible approaches to the simulation of antibiotic kinetics and the determination of antibacterial activity in vitro. Journal of Antimicrobial Chemotherapy. 15(suppl A). 117–120. 4 indexed citations

13.

Zák, O., W. TOSCH, & Merle A. Sande. (1985). Correlation of antibacterial activities of antibiotics in vitro and in animal models of infection. Journal of Antimicrobial Chemotherapy. 15(suppl A). 273–282. 28 indexed citations

14.

TOSCH, W., et al.. (1983). Cephalosporin antibiotics. Synthesis and antimicrobial activity of 7.BETA.-(2-(5-amino-1,2,4-thiadiazol-3-yl)-2-oxyiminoacetamido)cephalosporin derivatives.. The Journal of Antibiotics. 36(8). 1020–1033. 10 indexed citations

15.

Schneider, Peter, et al.. (1982). Antibacterial effects of Cefroxadine, Cephalexin and Cephradine in a new in vitro pharmacokinetic model.. The Journal of Antibiotics. 35(7). 843–849. 8 indexed citations

16.

Zák, O., et al.. (1979). Semisynthetic bicyclomycin derivatives: Preparation and antibacterial evaluation.. The Journal of Antibiotics. 32(7). 689–705. 15 indexed citations

17.

Zák, O., W. A. Vischer, W. TOSCH, et al.. (1976). CGP 9000: A new orally active, broad-spectrum cephalosporin.. The Journal of Antibiotics. 29(6). 653–655. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact